![Risk.net](https://www.risk.net/sites/default/files/styles/print_logo/public/2018-09/print-logo.png?itok=1TpHrpuP)
This article was paid for by a contributing third party.More Information.
![](/sites/default/files/styles/company_logo_center_left/public/2020-06/Bloomberg-logo-BB8.png.webp?itok=4tm9obW3)
The outlook for 2021 – FRTB
This three-part audiocast series explores some of the key topics and evolving challenges that will shape the agenda for capital markets participants in 2021.
This final episode considers market risk and the outlook for the Fundamental Review of the Trading Book (FRTB). Like many regulations, FRTB has been some time in the making, with Covid-19 forcing a further delay in the timeline. But the clock is ticking in Europe and the US in particular, with regulators stating their intention to start reviewing bank’s implementations this year.
Eugene Stern, head of market risk products at Bloomberg, reveals how banks are adapting their strategies in the current environment, and why FRTB affords banks a unique opportunity to develop a unified view on market risk and enhance their overall risk capabilities.
00:30 FRTB – the impact and objectives
04:36 Key pillars of a robust FRTB programme – how banks can enhance their risk capabilities and align internal risk management with FRTB requirements
09.20 How banks are adapting their strategies in the current environment
12.59 FRTB priorities and timelines for banks in 2021
Sponsored content
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@risk.net
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@risk.net